Weight-loss jab rollout hits one-month mark

Weight-loss jab rollout hits one-month mark

South Africa recently became the first African nation to introduce Wegovy, Novo Nordisk’s weight-loss injection. This weekly semaglutide jab, which shares an identical active ingredient with Ozempic, launched in the country just over a month ago. Since its debut, demand for the weight-loss jab has been high, but so have the barriers to access. For many South Africans, the cost remains out of reach. AT WHAT COST?  According to Reuters, one in two…